Advertisement
Home Blog Page 2406

July 2018 Briefing – Dermatology

0
Here are what the editors at HealthDay consider to be the most important developments in Dermatology for July 2018. This roundup includes the latest...

July 2018 Briefing – Cardiology

0
Here are what the editors at HealthDay consider to be the most important developments in Cardiology for July 2018. This roundup includes the latest...

July 2018 Briefing – Allergy

0
Here are what the editors at HealthDay consider to be the most important developments in Allergy for July 2018. This roundup includes the latest...
Despite their growing popularity

FDA Warns of the Dangers of ‘Vaginal Rejuvenation’

0
Numerous cases of vaginal burns or scarring have been linked to the procedures
Azedra (iobenguane) has been approved by the U.S. Food and Drug Administration to treat people 12 and older with rare adrenal gland tumors (pheochromocytoma or paraganglioma) that can't be surgically removed and have spread beyond the original site.

FDA Approves Azedra for Rare Adrenal Tumors

0
First systemic treatment for patients who experience tumor-related symptoms such as hypertension
Patients with rheumatoid arthritis

Flu Vaccine Cuts Mortality in Rheumatoid Arthritis Patients

0
Risk of hospitalization also reduced for RA patients receiving influenza vaccination
An increase in inpatient volume is associated with a greater increase in diversion hours for ambulances when the volume increase occurs among inpatients versus emergency department visitors

Inpatient Volume Greater Driver of Ambulance Diversion

0
10 percent increase in patient volume resulted in seven-fold greater increase in hours on diversion
Although physicians typically struggle with change

Learning to Change Important for Improving Practice

0
Physicians need to accept that the health care industry is changing and that change is difficult
Introduction of genomic screening into routine health care is dependent on demonstration of clinical utility

Demonstrating Clinical Use Will Speed Genomic Screening

0
Field could advance more quickly if data from research participants, consumers got to clinic
There are very few published descriptions of programs that address the mistreatment of medical trainees

Few Published Programs Address Medical Trainee Mistreatment

0
Most common format of program is combination of lectures, workshops, and seminars